Skip to content

Pharminent

cropped-ChatGPT-Image-May-28-2026-10_46_23-PM.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Other
  • S16 Ep38: Live Tumor Board: Precision Pathways Transforming Patient Care in Advanced NSCLC
  • Other

S16 Ep38: Live Tumor Board: Precision Pathways Transforming Patient Care in Advanced NSCLC

OncLive Podcast

In this podcast, experts Narjust Florez, MD, FASCO; David Carbone, MD, PhD; and Edward Garon, MD, MS; discuss the use of KRAS-, NRG1-, MET-, and ROS1-targeting agents to transform patient care in adva

OtherOncologyRead full story

pharminent March 27, 2026 (Last updated: March 30, 2026)

OncLive Podcast

In this podcast, experts Narjust Florez, MD, FASCO; David Carbone, MD, PhD; and Edward Garon, MD, MS; discuss the use of KRAS-, NRG1-, MET-, and ROS1-targeting agents to transform patient care in adva

OtherOncologyRead full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: Accord, Intas, and Bio-Thera File Four IPRs Against Janssen Golimumab Patents
Next: Lilly puts up to $2.75bn into Insilico alliance

Related Stories

  • Other

All eyes on Revolution, bispecific antibodies and more at ASCO26

pharminent May 26, 2026
  • Other

225: An Interview With Craig Martin, Founder and CEO of the Orphan Therapeutics Accelerator

pharminent May 18, 2026
  • Other

Cellbxhealth partners with AdventHealth on CTCbased monitoring in two major cancer studies

pharminent May 18, 2026

You May Have Missed

  • Policy / Pricing

Eli Lilly issues data sharing ultimatum to 340B hospitals

pharminent June 2, 2026
  • M&A / Deals

Fulcrum exploring a potential sale after FDA sidelined its sickle cell drug

pharminent June 2, 2026
  • Clinical Data

ASCO 2026: Kelonia presents positive in vivo CAR-T data in multiple myeloma

pharminent June 2, 2026
  • Clinical Data

ASCO26: In vivo oncology approaches continue to show promise

pharminent June 2, 2026
Copyright © 2026 All rights reserved. | ReviewNews by AF themes.